Blood Pressure Medication Recalled

February 26, 2019


The FDA has announced that Macleods Pharmaceuticals Limited is voluntarily recalling one lot of its high blood pressure medications, Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg, due to trace amounts of an unexpected impurity (NDEA) detected in the finished product.


NDEA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification.


Macleods Pharmaceuticals is recalling the single lot because the NDEA traces found exceed FDA daily intake limits.


So far the FDA nor Macleods Pharmaceuticals have received reports of adverse effects or events related to the recalled medication.


Patients currently taking the medication are urged to continue taking it as the risk of harm to the patient may be greater if the treatment is stopped immediately without an alternative treatment.


The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing these products.


The medication's information is:

  • NDC: 33342-0052-10

  • Manufacturer: Macleods Pharmaceuticals

  • Product Description: LimitedLosartan Potassium/ Hydrochlorothiazide combination tablets 100mg/25mg, 90 count bottles

  • Lot/Batch Number: BLM715A; Expiration Date: Jul -2019

 Article Sponsored By



Share on Facebook
Share on Twitter
Please reload

Instagram Feed
Follow Us
  • Facebook Social Icon
  • YouTube Social  Icon
  • Twitter Social Icon
  • Instagram Social Icon
  • RSS Social Icon
News Archives
Please reload


    Like what you read? Donate now and help LPNN provide fresh news and analysis for our readers   

© 2017 Lake Powell News Network, LLC